Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
US8277847B2 · kind B2 · utility
3Cited by
47References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 13, 2009 |
| Grant date | Oct 2, 2012 |
| Priority date | — |
| Expiry date | Dec 9, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Lipidated glycosaminoglycan particles, prepared by reacting a glycosaminoglycan with at least one lipid to cross-link the carboxylic acid groups in the glycosaminoglycan with a primary amine in the lipid, are used to encapsulate drugs for use in the treatment of pathological conditions in an animal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.